May 10, 2018 / 12:37 PM / 13 days ago

BRIEF-Heron Therapeutics Reports Quarterly Loss Per Share Of $0.81

May 10 (Reuters) - Heron Therapeutics Inc:

* HERON THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2018 AND RECENT CORPORATE PROGRESS

* QUARTERLY LOSS PER SHARE $0.81

* REAFFIRMS FULL-YEAR 2018 CINV FRANCHISE NET PRODUCT SALES GUIDANCE OF $60 MILLION TO $70 MILLION

* QTRLY NET PRODUCT SALES $11.6 MILLION VERSUS $3.6 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below